How to assess minimal residual disease in pediatric and adult acute myeloid leukemia?
Transl Pediatr
.
2013 Apr;2(2):80-3.
doi: 10.3978/j.issn.2224-4336.2013.04.09.
Authors
Gerrit J Schuurhuis
1
,
Jacqueline Cloos
1
,
Gert J Ossenkoppele
1
Affiliation
1
1 Department of Haematology, 2 Department of Haematology and Pediatric Oncology/Haematology, Cancer Center Amsterdam, VU Institute for Cancer and Immunology, VU University Medical Center, Amsterdam, The Netherlands.
PMID:
26835296
PMCID:
PMC4728920
DOI:
10.3978/j.issn.2224-4336.2013.04.09
No abstract available